Trial intelligence / Profile preview

Zesteem for healing skin graft donor sites

NCT00426972Phase 3Completed

Sponsor
Renovo
Start
Jan 2007
Primary completion
Jul 2008
Modality
Hormone, Biologic
Countries
4
01

Overview

A Phase 3 trial of estradiol in skin graft donor-site wound (SGDW), sponsored by Renovo. Started Jan 2007; status: completed.

02

Drugs

estradiol
03

Conditions

skin graft donor-site wound (SGDW)

Beyond the preview

Go deeper on NCT00426972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00426972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call